Results of Phase I Tolerability LX214 (0.2%) Voclosporin Topical Solution in Healthy Volunteers and Subjects With Dry Eye Disease
用户qgRSP4os3S6M
24天前
39
10
已关闭
DOI:
文献链接:
其他信息:
MA Lemp, R Beckman, S Weiss
… Ophthalmology